Cisapride for the treatment of nausea produced by selective serotonin reuptake inhibitors



	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted



	Email this article to a Colleague
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to My Articles & Searches
	Download to citation manager



	Citing Articles via HighWire
	Citing Articles via Google Scholar



	Articles by Bergeron, R.
	Articles by Blier, P.
	Search for Related Content



	PubMed Citation
	Articles by Bergeron, R.
	Articles by Blier, P.

Am J Psychiatry 1994; 151:1084-1086
Copyright © 1994 by American Psychiatric Association

REGULAR ARTICLES

Cisapride for the treatment of nausea produced by selective serotonin reuptake inhibitors

R Bergeron and P Blier
Department of Psychiatry, McGill University, Montreal, Que., Canada.

A low dose of cisapride (5 mg b.i.d.) produced rapid relief from nausea elicited by the initiation of treatment with a selective serotonin reuptake inhibitor in eight patients. This effect of cisapride is presumably related to its serotonin3 antagonistic property.

This article has been cited by other articles:

R. Twycross, M.W. Greaves, H. Handwerker, E.A. Jones, S.E. Libretto, J.C. Szepietowski, and Z. Zylicz
Itch: scratching more than the surface
QJM, January 1, 2003; 96(1): 7 - 26.
[Abstract] [Full Text] [PDF]

B. J. Goldstein and P. J Goodnick
Selective serotonin reuptake inhibitors in the treatment of affective disorders--III. Tolerability, safety and pharmacoeconomics
J Psychopharmacol, January 1, 1998; 12(4_suppl): 55 - S87.
[Abstract] [PDF]

J. E. Bailey, J. Potokar, N. Coupland, and D. J. Nutt
The 5-HT3 antagonist ondansetron reduces gastrointestinal side effects induced by a specific serotonin re-uptake inhibitor in man
J Psychopharmacol, January 1, 1995; 9(2): 137 - 141.
[Abstract] [PDF]

Get information about faster international access.